Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-L1 PET imaging in DLBCL patients treated with CD19-directed CAR T-cell therapy
2024-518422-32-01Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atezolizumab in diffuse large B-cell lymphoma (DLBCL), sponsored by University Medical Center Groningen. Started Nov 2024; status: completed.
02
Drugs
atezolizumab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on 2024-518422-32-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518422-32-01.